Chronic obstructive pulmonary disease (COPD) is a disease characterized by progressive
airflow limitation that is not fully reversible and is accompanied by extra-pulmonary
effects that can lead to important co-morbidities. The treatment of COPD is associated
with substantial healthcare costs, which are expected to increase in the future. Therefore
the need for information on efficient treatment options in terms of both effects and
costs is high. This thesis aims to investigate the costs and cost-effectiveness of treatment
options for COPD to contribute to evidence-based policy making. This introduction
provides background information on COPD and describes the disease characteristics,
epidemiology, the social and economic burden and the available treatment options and
their potential cost-effectiveness.
http://repub.eur.nl/res/pub/30595/111129_%20Hoogendoorn-Lips%2C%20Elizabeth%20Jantina%20Ike%20%28Martine%29.pdf
http://repub.eur.nl/res/pub/30595/111129_%20Hoogendoorn-Lips%2C%20Elizabeth%20Jantina%20Ike%20%28Martine%29.pdf
No comments:
Post a Comment